Startseite Crystal structure of 1-(p-tolylphenyl)-4-(2-thienoyl)-3-methyl-1H-pyrazol-5-ol, C16H14N2O2S
Artikel Open Access

Crystal structure of 1-(p-tolylphenyl)-4-(2-thienoyl)-3-methyl-1H-pyrazol-5-ol, C16H14N2O2S

  • Tong-Yin Jin , Jia-Ning Yang , Hong-Li Chen , Heng-Qiang Zhang ORCID logo und Lian-Yan Liao EMAIL logo
Veröffentlicht/Copyright: 8. April 2025
Artikel downloaden (PDF)
Veröffentlichen auch Sie bei De Gruyter Brill
Manuskript einreichen Informationen für Autor*innen
Zeitschrift für Kristallographie - New Crystal Structures
Aus der Zeitschrift Zeitschrift für Kristallographie - New Crystal Structures Band 240 Heft 3

Abstract

C16H14N2O2S, orthorhombic, Pca21 (no. 29), a = 11.5382(5) Å, b = 8.2480(5) Å, c = 15.1726(11) Å, V = 1,443.94(15) Å3, Z = 4, Rgt (F) = 0.0379, wRref (F 2) = 0.0990, T = 173 K.

CCDC no.: 2433189

1 Source of material

All reagents were sourced from commercial suppliers and used as received without additional purification. The synthesis of 3-methyl-1-p-tolyl-5-pyrazolone followed the method outlined by Jensen, 4 resulting in an 80.5 % yield and a melting point of 402–403 K o prepare the compound, 5 g of 3-methyl-1-p-tolyl-5-pyrazolone was dissolved in 100 mL of dioxane with gentle heating, after which 3 g of Ca(OH)2 was added. Next, 5 mL of 2-thiophenecarbonyl chloride was added dropwise while stirring over a period of 4 min. The mixture was then refluxed gently for 1 h, cooled, and poured into 420 mL of chilled 2.5 M HCl while stirring. A small amount of an ice-salt mixture was added, and stirring continued vigorously for another 30 min. The reaction mixture was then placed in a refrigerator until crystallization occurred. The resulting product was filtered, yielding yellow crystals with an 80.5 % yield at room temperature.

Table 1:

Data collection and handling.

Crystal: Yellow block
Size: 0.18 × 0.14 × 0.12 mm
Wavelength:

μ:		 Mo Kα radiation (0.71073 Å)

0.23 mm−1
Diffractometer, scan mode:

θ max, completeness:		 Xcalibur, ω scan

29.4°, 100 %
N(hkl)measured, N(hkl)unique, R int: 10820, 3977, 0.024
Criterion for I obs, N(hkl)gt: I obs > 2σ(I obs), 2813
N(param)refined: 196
Programs: Rigaku, 1 SHELX 2 , 3

2 Experimental details

The H atom bonded to N2 was located in a difference Fourier map and refined freely. Other H atoms were placed in calculated positions, with C–H = 0.93 for phenyl and thiophene, 0.96 for methyl H atoms, and refined as riding, with U iso(H) = 1.2 U eq(C) for phenyl H and 1.5 U eq(C) for methyl H.

3 Discussion

Acylpyrazolones represent a fascinating group of β-diketone compounds that are commonly utilized for solvent extraction of metal ions, as materials for lasers, and as NMR shift reagents. 5 , 6 , 7 The metal complexes formed with these compounds have shown catalytic properties, biological activity, and improved luminescence. 8 Furthermore, they hold promise as antifungal agrochemicals, as well as for use in medicine for antiviral, antipyretic analgesic, and anti-inflammatory purposes. 9 , 10 Although there have been many studies on acylpyrazolones, only a limited number of 4-heterocyclic acylpyrazolone compounds have been reported so far. 11 , 12 Moreover, research has been restricted to those acylpyrazolones with alkyl or aryl substituents at the 4-positions. Only a few studies have involved heterocyclic substituents at the 4-positions. 13 In order to expand this field, the title compound was synthesized, and its crystal structure is reported herein.

The structure of the title compound is shown in Figure. The molecule is distinctly non-planar. Moreover, the two C=O functionalities are oriented trans to each other not permitting an intramolecular hydrogen bond. The active hydrogen atom is attached to the nitrogen atom N2 and involved in an N–H⋯O hydrogen bond of N⋯O = 2.685 Å to the pyrazolone oxygen of a neighboring molecule. The p-tolylphenyl ring is slightly twisted by 17.11(6)° with respect to the pyrazolone ring, whereas the p-tolylphenyl and pyrazolone rings make dihedral angles of 52.06(5)° and 56.39(8)°, respectively, with the thenoyl ring. Atom O2 has a partial anionic character, as shown by the lengthening of the C=O bond [1.212(2) Å] relative to that normally found for carbonyl groups. All geometric parameters are in the expected ranges. 14 , 15

Corresponding author: Lian-Yan Liao, Department of Chemistry, Hebei Minzu Normal University, Chengde 067000, People’s Republic of China, E-mail:

Acknowledgments

The authors thank the Science Foundation of Hebei Minzu Normal University (DR 2023001) and Research on the Key Technologies for Collaborative Development of Clean Energy Development and Ecological Protection in Chengde (No. 202305B100) support.

References

1. Rigaku, O. D. CrysAlisPRO; Rigaku Oxford Diffraction Ltd: Yarnton, Oxfordshire, England, 2015.Suche in Google Scholar

2. Sheldrick, G. M. SHELXL2018. Crystal Structure Refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8.Suche in Google Scholar

3. Sheldrick, G. M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

4. Jensen, B. S. The Synthesis of 1-Phenyl-3-Methyhl-4-Acyl-Pyrazolones-5. Acta Chem. Scand. 1959, 13, 1668–1670; https://doi.org/10.3891/acta.chem.scand.13-1668.Suche in Google Scholar

5. Marchetti, F.; Pettinari, C.; Di Nicola, C.; Tombesi, A.; Pettinari, R. Coordination Chemistry of Pyrazolone-Based Ligands and Applications of Their Metal Complexes. Coord. Chem. Rev. 2019, 401, 213069; https://doi.org/10.1016/j.ccr.2019.213069.Suche in Google Scholar

6. Wang, X. H.; Jia, D. Z.; Liang, Y. J.; Yan, S. L.; Ding, Y.; Chen, L. M.; Shi, Z.; Zeng, M. S.; Liu, G. F.; Fu, L. W. Lgf–YL-9 Induces Apoptosis in Human Epidermoid Carcinoma KB Cells and Multidrug Resistant KBv200 Cells via Reactive Oxygen Species-independent Mitochondrial Pathway. Cancer Lett. 2007, 249, 256–270; https://doi.org/10.1016/j.canlet.2006.09.008.Suche in Google Scholar PubMed

7. El-Gaby, M. S.; Atalla, A. A.; Gaber, A. M.; Al-Wahab, K. A. Studies on Aminopyrazoles: Antibacterial Activity of Some Novel Pyrazol. Farmaco 2000, 55, 596–602; https://doi.org/10.1016/s0014-827x(00)00079-3.Suche in Google Scholar PubMed

8. Timerbaev, A. R.; Rudnev, A. V.; Semenova, O.; Hartinger, C. G.; Keppler, B. K. Comparative Binding of Antitumor Indazolium [trans-Tetrachlorobi s(1H-indazole)Ruthenate(III)] to Serum Transport Proteins Assayed by Capillary Zone Electrophoresis. Anal. Biochem. 2005, 341, 326–333; https://doi.org/10.1016/j.ab.2005.03.020.Suche in Google Scholar PubMed

9. Mukherjee, R. Coordination Chemistry with Pyrazole-Based Chelating Ligands: Molecular Structural Aspects. Coord. Chem. Rev. 2000, 203, 151–158; https://doi.org/10.1016/s0010-8545(99)00144-7.Suche in Google Scholar

10. Raman, N.; Selvaganapathy, M. Pyrazolone Incorporating Amino Acid Metallointercalators as Effective DNA Targets: Synthesis and In Vitro Biocidal Evaluation. Inorg. Chem. Commun. 2013, 37, 114–120; https://doi.org/10.1016/j.inoche.2013.09.028.Suche in Google Scholar

11. Sun, R. X.; Li, J. Z.; Zhang, H. Q.; Pang, X. Z.; Fu, Y. S.; Cui, J. Z. Synthesis, Crystal Structure, Characterization and DNA Binding Studies of Novel Copper (II) Complex Based on Amino Acid Schiff Base. Curr. Org. Chem. 2012, 16, 2868–2878; https://doi.org/10.2174/138527212804546912.Suche in Google Scholar

12. Wu, Q.; Huang, Z.-Y.; Liu, Y.-X.; Zhang, H.-Q.; Jin, T.-Y.; Xue, Y.-N.; Liu, C. Crystal Structure of 1-(p-Tolylphenyl)-4-(2-furoyl)-3-methyl-1H-pyrazol-5-Ol, C16H14N2O3. Z. Kristallogr. New Cryst. Struct. 2024, 239, 327–329; https://doi.org/10.1515/ncrs-2024-0001.Suche in Google Scholar

13. Wu, Q.; Zhang, W.-Y.; Zhang, Z.-M.; Zhang, H.-Q.; Jin, T.-Y. Crystal Structure of 1-(4-Chlorophenyl)-4-(2-furoyl)-3-phenyl-1H-pyrazol-5-ol, C20H13ClN2O. Z. Kristallogr. New Cryst. Struct. 2024, 239, 565–567; https://doi.org/10.1515/ncrs-2024-0097.Suche in Google Scholar

14. Ding, Y.-J.; Zhao, C.-X.; Pei, C.-Yu.; Wen, G.-X. Synthesis, Properties and Crystal Structure of a Novel Ni(II) Complex Derived from a 4-Heterocyclic Acylpyrazolone. Z. Naturforsch. B. 2012, 67, 204–208; https://doi.org/10.5560/znb.2012.67b0204.Suche in Google Scholar

15. Holzer, W.; Mereiter, K.; Plagens, B. 4-Acyl-5-methyl-2-phenylpyrazolones: NMR and X-Ray Structure Investigations. Heterocycles 1999, 50, 799; https://doi.org/10.3987/com-98-s(h)74.Suche in Google Scholar
Received: 2025-02-19
Accepted: 2025-03-21
Published Online: 2025-04-08
Published in Print: 2025-06-26

© 2025 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of 5,5′-bis(2,4,6-trinitrophenyl)-2,2′-bi(1,3,4-oxadiazole), C16H4N10O14
  4. Crystal structure of catena-poly[(μ3-4,4′-oxydibenzoato- κ5 O,O′: O″,O‴:O‴)-bis(2,4,6-tri(3-pyridine)-1,3,5-triazine-κ1 N)cadmium(II)], C50H32CdN12O5
  5. The crystal structure of 1,4-diazepane-1,4-diium potassium trinitrate, C5H14KN5O9
  6. The crystal structure of benzyl 2,2,5,5-tetramethylthiazolidine-4-carboxylate, C15H21NO2S
  7. Crystal structure of 2-hydroxyethyl-triphenylphosphonium tetracyanidoborate, C24H20BN4OP
  8. The crystal structure of 1-methyl-3-(N-methylnitrous amide–N-methylene) imidazolidine-2,4,5-trione
  9. Crystal structure of N-((3-cyano-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-(2,2,2-trifluoroacetyl)-1H-pyrazol-5-yl)carbamoyl)-2,6-difluorobenzamide, C20H7Cl2F8N5O3S
  10. Crystal structure of 5-(2,2-difluoropropyl)-5-methylbenzo[4,5]imidazo[2,1-a] isoquinolin-6(5H)-one, C20H18F2N2O
  11. The crystal structure of N′,N″-[1,2-bis(4-chlorophenyl)ethane-1,2-diylidene]bis(furan-2- carbohydrazide), C24H16Cl2N4O4
  12. Crystal structure of [(4-bromobenzyl)triphenylphosphonium] tetrabromoantimony(III), [C25H21BrP]+[SbBr4]−
  13. Crystal structure of [(4-bromobenzyl)triphenylphosphonium] tetrabromidoindium(III), [C25H21BrP]+[InBr4]−
  14. The crystal structure of 4-carboxy-2-oxobutan-1-aminium chloride, C5H10ClNO3
  15. Crystal structure of (4-(4-chlorophenyl)-1H-pyrrole-3-carbonyl)ferrocene, C21H16ClFeNO
  16. The crystal structure of dichlorido(η6-p-cymene)(triphenylarsine)ruthenium(II), C28H29AsCl2Ru
  17. Crystal structure of (Z)-2-hydroxy-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H16N2O2
  18. The crystal structure of 10-(1-bromoethyl)-14-(bromomethyl)dibenzo[a, c]acridine, C24H17NBr2
  19. Synthesis and crystal structure of 6-methoxy-7-[(4-methoxyphenyl)methoxy]-2H-1-benzopyran-2-one, C18H16O5
  20. Synthesis and crystal structure of ethyl 4-((4-trifluoromethylbenzyl)amino)benzo, C17H16F3NO2
  21. The crystal structure of (Z)-2-(tert-butyl)-6-(7-(tert-butyl)-5-methylbenzo[d][1,3]oxathiol-2-ylidene)-4-methylcyclohexa-2,4-dien-1-one, C23H28O2S
  22. The crystal structure of (R)-2-aminobutanamide hydrochloride, C4H11ClN2O
  23. Crystal structure of bromido[hydridotris(3-tert-butyl-5-isopropylpyrazolyl)borato-κ3 N,N′,N″]copper(II), C30H52BBrCuN6
  24. Crystal structure of chlorido{hydridotris[3-mesityl-5-methyl-1H-pyrazol-1-yl-κN3]borato}-copper(II) dichloromethane monosolvate
  25. Crystal structure of 4-[3,5-bis(propan-2-yl)-1H-pyrazol-4-yl]pyridine, C14H19N3
  26. Crystal structure of ((4-(4-bromophenyl)-1H-pyrrol-3-yl)methyl)ferrocene, C21H16BrFeNO
  27. Crystal structure of [(4-chlorobenzyl)triphenylphosphonium] dichloridocopper(I), {[C25H21ClP]+[CuCl2]−}n
  28. The crystal structure of {Cu(2,9-diisopropyl-4,7-diphenyl-1,10-phenanthroline)[4,5-bis(diphenylphosphino)-9,9-dimethylxanthene]}+ PF6−·1.5(EtOAC)
  29. Crystal structure of 3,5-bis(t-butyl)-1H-pyrazol-4-amine, C11H21N3
  30. Crystal structure of [(2,4-dichlorobenzyl)triphenylphosphonium] trichloridocopper(II), [C25H20Cl2P]+[CuCl3]−
  31. The crystal structure of dipotassium sulfide, K2S
  32. Crystal structure of (4-(4-methoxyphenyl)-1H-pyrrole-3-carbonyl)ferrocene, C22H19FeNO2
  33. Crystal structure of (E)-6-(4-methylpiperazin-1-yl)-2-(4-(trifluoromethyl)benzylidene)-3, 4-dihydronaphthalen-1(2H)-one, C23H23F3N2O
  34. Crystal structure of (E)-6-morpholino-2-(4-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H20F3NO2
  35. Crystal structure of Ce9Ir37Ge25
  36. The crystal structure of ethyl 6-(2-nitrophenyl)imidazo[2,1-b]thiazole-3-carboxylate, C14H11N3O4S
  37. Crystal structure of (4-(4-isopropylphenyl)-1H-pyrrol-3-yl)(ferrocenyl)methanone, C24H23FeNO
  38. Crystal structure of bis(methylammonium) tetrathiotungstate(VI), (CH3NH3)2[WS4]
  39. Crystal structure of 6,11-dihydro-12H-benzo[e]indeno[1,2-b]oxepin-12-one, C17H12O2
  40. Crystal structure of 3-[(4-phenylpiperidin-1-yl)methyl]-5-(thiophen-2-yl)-2,3-dihydro-1,3,4- oxadiazole-2-thione, C18H19N3OS2
  41. Crystal structure of N-isopropyl-1,8-naphthalimide C15H13NO2
  42. TiNiSi-type EuPdBi
  43. Crystal structure of 1-(p-tolylphenyl)-4-(2-thienoyl)-3-methyl-1H-pyrazol-5-ol, C16H14N2O2S
  44. The crystal structure of 3-(3-carboxypropyl)-2-nitro-1H-pyrrole 1-oxide, C7H9N3O5
  45. The crystal structure of tetraaqua-bis(2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetato-k2O:N)-tetrakis(2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetato-k1N)trizinc(II) hexahydrate C36H52N18O32Zn3
  46. The crystal structure of 4-(3-carboxy-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)piperazin-1-ium 4-hydroxy-3,5-dimethoxybenzoate monohydrate, C25H30FN3O9
  47. Crystal structure of bis(DL-1-carboxy-2-(1H-indol-3-yl)ethan-1-aminium) oxalate — acetic acid (1/2)
  48. Crystal structure of methyl (E)-4-((4-methylphenyl)sulfonamido)but-2-enoate, C12H15NO4S
  49. The crystal structure of actarit, C10H11NO3
  50. The crystal structure of bicyclol, C19H18O9
  51. The crystal structure of topiroxostat, C13H8N6
  52. Crystal structure of 2,2-dichloro-N-methyl-N-(4-p-tolylthiazol-2-yl)acetamide, C13H12Cl2N2OS
  53. Crystal structure of 4-(trifluoromethyl)-7-coumarinyl trifluoromethanesulfonate C11H4F6O5S
  54. Crystal structure of (1,4,7,10,13,16-hexaoxacyclooctadecane-κ6O6)-((Z)-N,N′-bis(2-(dimethylamino)phenyl)carbamimidato-κ1N)potassium(I)
  55. Crystal structure of (Z)-2-(5-((4-(dimethylamino)naphthalen-1-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid, C18H16N2O3S2
  56. Crystal structure of (4-fluorobenzyl)triphenylphosphonium bromide, C25H21BrFP
  57. The crystal structure of dichlorido-[6-(pyridin-2-yl)phenanthridine-κ2N, N′]zinc(II)-chloroform (1/1), C19H13N2ZnCl5
  58. Crystal structure of (E)-(3-(2,4-dichlorophenyl)acryloyl)ferrocene, C19H14Cl2FeO
  59. The crystal structure of (E)-7-chloro-1-cyclopropyl-6-fluoro-3-((2-hydroxybenzylidene)amino)quinolin-4(1H)-one, C19H14ClFN2O2
  60. Crystal structure of 2-bromo-11-(((fluoromethyl)sulfonyl)methyl)-6-methyl-6,11-dihydrodibenzo[c,f][1,2]thiazepine 5,5-dioxide, C16H13BrFNO4S2
  61. Crystal structure of 2-chloro-11-(((fluoromethyl)sulfonyl)methyl)-6-methyl-6,11-dihydrodibenzo[c,f][1,2]thiazepine 5,5-dioxide, C16H13ClFNO4S2
  62. Crystal structure of 5-(2,2-difluoropropyl)-5-methyl-6-oxo-5,6-dihydrobenzo[4,5]imidazo[2,1-a]isoquinoline-3-carbonitrile, C20H15F2N3O
https://doi.org/10.1515/ncrs-2025-0083
Creative Commons
BY 4.0

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of 5,5′-bis(2,4,6-trinitrophenyl)-2,2′-bi(1,3,4-oxadiazole), C16H4N10O14
  4. Crystal structure of catena-poly[(μ3-4,4′-oxydibenzoato- κ5 O,O′: O″,O‴:O‴)-bis(2,4,6-tri(3-pyridine)-1,3,5-triazine-κ1 N)cadmium(II)], C50H32CdN12O5
  5. The crystal structure of 1,4-diazepane-1,4-diium potassium trinitrate, C5H14KN5O9
  6. The crystal structure of benzyl 2,2,5,5-tetramethylthiazolidine-4-carboxylate, C15H21NO2S
  7. Crystal structure of 2-hydroxyethyl-triphenylphosphonium tetracyanidoborate, C24H20BN4OP
  8. The crystal structure of 1-methyl-3-(N-methylnitrous amide–N-methylene) imidazolidine-2,4,5-trione
  9. Crystal structure of N-((3-cyano-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-(2,2,2-trifluoroacetyl)-1H-pyrazol-5-yl)carbamoyl)-2,6-difluorobenzamide, C20H7Cl2F8N5O3S
  10. Crystal structure of 5-(2,2-difluoropropyl)-5-methylbenzo[4,5]imidazo[2,1-a] isoquinolin-6(5H)-one, C20H18F2N2O
  11. The crystal structure of N′,N″-[1,2-bis(4-chlorophenyl)ethane-1,2-diylidene]bis(furan-2- carbohydrazide), C24H16Cl2N4O4
  12. Crystal structure of [(4-bromobenzyl)triphenylphosphonium] tetrabromoantimony(III), [C25H21BrP]+[SbBr4]−
  13. Crystal structure of [(4-bromobenzyl)triphenylphosphonium] tetrabromidoindium(III), [C25H21BrP]+[InBr4]−
  14. The crystal structure of 4-carboxy-2-oxobutan-1-aminium chloride, C5H10ClNO3
  15. Crystal structure of (4-(4-chlorophenyl)-1H-pyrrole-3-carbonyl)ferrocene, C21H16ClFeNO
  16. The crystal structure of dichlorido(η6-p-cymene)(triphenylarsine)ruthenium(II), C28H29AsCl2Ru
  17. Crystal structure of (Z)-2-hydroxy-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H16N2O2
  18. The crystal structure of 10-(1-bromoethyl)-14-(bromomethyl)dibenzo[a, c]acridine, C24H17NBr2
  19. Synthesis and crystal structure of 6-methoxy-7-[(4-methoxyphenyl)methoxy]-2H-1-benzopyran-2-one, C18H16O5
  20. Synthesis and crystal structure of ethyl 4-((4-trifluoromethylbenzyl)amino)benzo, C17H16F3NO2
  21. The crystal structure of (Z)-2-(tert-butyl)-6-(7-(tert-butyl)-5-methylbenzo[d][1,3]oxathiol-2-ylidene)-4-methylcyclohexa-2,4-dien-1-one, C23H28O2S
  22. The crystal structure of (R)-2-aminobutanamide hydrochloride, C4H11ClN2O
  23. Crystal structure of bromido[hydridotris(3-tert-butyl-5-isopropylpyrazolyl)borato-κ3 N,N′,N″]copper(II), C30H52BBrCuN6
  24. Crystal structure of chlorido{hydridotris[3-mesityl-5-methyl-1H-pyrazol-1-yl-κN3]borato}-copper(II) dichloromethane monosolvate
  25. Crystal structure of 4-[3,5-bis(propan-2-yl)-1H-pyrazol-4-yl]pyridine, C14H19N3
  26. Crystal structure of ((4-(4-bromophenyl)-1H-pyrrol-3-yl)methyl)ferrocene, C21H16BrFeNO
  27. Crystal structure of [(4-chlorobenzyl)triphenylphosphonium] dichloridocopper(I), {[C25H21ClP]+[CuCl2]−}n
  28. The crystal structure of {Cu(2,9-diisopropyl-4,7-diphenyl-1,10-phenanthroline)[4,5-bis(diphenylphosphino)-9,9-dimethylxanthene]}+ PF6−·1.5(EtOAC)
  29. Crystal structure of 3,5-bis(t-butyl)-1H-pyrazol-4-amine, C11H21N3
  30. Crystal structure of [(2,4-dichlorobenzyl)triphenylphosphonium] trichloridocopper(II), [C25H20Cl2P]+[CuCl3]−
  31. The crystal structure of dipotassium sulfide, K2S
  32. Crystal structure of (4-(4-methoxyphenyl)-1H-pyrrole-3-carbonyl)ferrocene, C22H19FeNO2
  33. Crystal structure of (E)-6-(4-methylpiperazin-1-yl)-2-(4-(trifluoromethyl)benzylidene)-3, 4-dihydronaphthalen-1(2H)-one, C23H23F3N2O
  34. Crystal structure of (E)-6-morpholino-2-(4-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H20F3NO2
  35. Crystal structure of Ce9Ir37Ge25
  36. The crystal structure of ethyl 6-(2-nitrophenyl)imidazo[2,1-b]thiazole-3-carboxylate, C14H11N3O4S
  37. Crystal structure of (4-(4-isopropylphenyl)-1H-pyrrol-3-yl)(ferrocenyl)methanone, C24H23FeNO
  38. Crystal structure of bis(methylammonium) tetrathiotungstate(VI), (CH3NH3)2[WS4]
  39. Crystal structure of 6,11-dihydro-12H-benzo[e]indeno[1,2-b]oxepin-12-one, C17H12O2
  40. Crystal structure of 3-[(4-phenylpiperidin-1-yl)methyl]-5-(thiophen-2-yl)-2,3-dihydro-1,3,4- oxadiazole-2-thione, C18H19N3OS2
  41. Crystal structure of N-isopropyl-1,8-naphthalimide C15H13NO2
  42. TiNiSi-type EuPdBi
  43. Crystal structure of 1-(p-tolylphenyl)-4-(2-thienoyl)-3-methyl-1H-pyrazol-5-ol, C16H14N2O2S
  44. The crystal structure of 3-(3-carboxypropyl)-2-nitro-1H-pyrrole 1-oxide, C7H9N3O5
  45. The crystal structure of tetraaqua-bis(2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetato-k2O:N)-tetrakis(2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetato-k1N)trizinc(II) hexahydrate C36H52N18O32Zn3
  46. The crystal structure of 4-(3-carboxy-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)piperazin-1-ium 4-hydroxy-3,5-dimethoxybenzoate monohydrate, C25H30FN3O9
  47. Crystal structure of bis(DL-1-carboxy-2-(1H-indol-3-yl)ethan-1-aminium) oxalate — acetic acid (1/2)
  48. Crystal structure of methyl (E)-4-((4-methylphenyl)sulfonamido)but-2-enoate, C12H15NO4S
  49. The crystal structure of actarit, C10H11NO3
  50. The crystal structure of bicyclol, C19H18O9
  51. The crystal structure of topiroxostat, C13H8N6
  52. Crystal structure of 2,2-dichloro-N-methyl-N-(4-p-tolylthiazol-2-yl)acetamide, C13H12Cl2N2OS
  53. Crystal structure of 4-(trifluoromethyl)-7-coumarinyl trifluoromethanesulfonate C11H4F6O5S
  54. Crystal structure of (1,4,7,10,13,16-hexaoxacyclooctadecane-κ6O6)-((Z)-N,N′-bis(2-(dimethylamino)phenyl)carbamimidato-κ1N)potassium(I)
  55. Crystal structure of (Z)-2-(5-((4-(dimethylamino)naphthalen-1-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid, C18H16N2O3S2
  56. Crystal structure of (4-fluorobenzyl)triphenylphosphonium bromide, C25H21BrFP
  57. The crystal structure of dichlorido-[6-(pyridin-2-yl)phenanthridine-κ2N, N′]zinc(II)-chloroform (1/1), C19H13N2ZnCl5
  58. Crystal structure of (E)-(3-(2,4-dichlorophenyl)acryloyl)ferrocene, C19H14Cl2FeO
  59. The crystal structure of (E)-7-chloro-1-cyclopropyl-6-fluoro-3-((2-hydroxybenzylidene)amino)quinolin-4(1H)-one, C19H14ClFN2O2
  60. Crystal structure of 2-bromo-11-(((fluoromethyl)sulfonyl)methyl)-6-methyl-6,11-dihydrodibenzo[c,f][1,2]thiazepine 5,5-dioxide, C16H13BrFNO4S2
  61. Crystal structure of 2-chloro-11-(((fluoromethyl)sulfonyl)methyl)-6-methyl-6,11-dihydrodibenzo[c,f][1,2]thiazepine 5,5-dioxide, C16H13ClFNO4S2
  62. Crystal structure of 5-(2,2-difluoropropyl)-5-methyl-6-oxo-5,6-dihydrobenzo[4,5]imidazo[2,1-a]isoquinoline-3-carbonitrile, C20H15F2N3O
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 17.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2025-0083/html
Button zum nach oben scrollen